Comparison · documented facts only
We have read Pearl (Second Opinion 3D)'s own website and placed it side by side with what Clinaxia documents. Where Pearl (Second Opinion 3D) does not mention a feature, we write “not stated” — not “no”.
9
features Clinaxia documents that Pearl (Second Opinion 3D) does not state or lacks
3
features both document
2
features Pearl (Second Opinion 3D) documents that Clinaxia does not have yet
Clinaxia price
Solo NOK 1,715 · Clinic NOK 1,140 per clinician/mo, ex. VAT
Public price
Pearl (Second Opinion 3D) price
Not published on hellopearl.com (demo/contact)
Price not published
Where Clinaxia documents more
Features documented in Clinaxia that Pearl (Second Opinion 3D) either says no to, covers partially or does not mention on its website.
Voice → record draft
Pearl (Second Opinion 3D): Not stated
HELFO tariff control vs. official source
103 tariff codes verified figure by figure against the Directorate of Health circular and auto-cross-checked against Helfo open data
Pearl (Second Opinion 3D): Not stated
Voice-driven perio charting
Pearl (Second Opinion 3D): Not stated
Drug interaction check
Pearl (Second Opinion 3D): Not stated
Referral / discharge / letters
Pearl (Second Opinion 3D): Partial — “One-click” referral to a US board-certified radiologist inside the product – not Norwegian referral/discharge letters
Appointments and recall
Pearl (Second Opinion 3D): Not stated
Patient communication
Pearl (Second Opinion 3D): Not stated
AI shows its source (grounding)
Grounding score on every AI block — try it on /evidens
Pearl (Second Opinion 3D): Not stated
Flat price, all AI included
Pearl (Second Opinion 3D): Not stated
What Pearl (Second Opinion 3D) documents that we do not have — yet
We do not hide this. Here is Clinaxia's status on each point.
Practice-system integration
Pearl (Second Opinion 3D): Yes — Integrations with imaging/practice systems in the US market (Pearl Connect)
Clinaxia: Partial — Opus export (clipboard/file); PMS integration in Enterprise tier
CE-marked (EU MDR)
Pearl (Second Opinion 3D): Yes — States FDA clearance for both 2D and 3D; CE marking mentioned for Second Opinion (class not stated on the page)
Clinaxia: Partial — Application pending — Clinaxia is decision support, not CE-marked diagnostics
Both document
| Feature | Clinaxia | Pearl (Second Opinion 3D) |
|---|---|---|
| Target group | Dental (complete clinical platform) | Dental imaging AI: 2D X-ray (Second Opinion) and CBCT (Second Opinion 3D) – segmentation, pathology detection, documentation and radiologist referral. Not a practice system. |
| Price (from vendor website) | Solo NOK 1,715 · Clinic NOK 1,140 per clinician/mo, ex. VATPublic price | Not published on hellopearl.com (demo/contact)Price not published |
| Trial | 7 days, no card (pilot 60) | Not stated (book a demo) |
| Languages | NO · SV · DA · EN | English (Norwegian not stated) |
| Built for dentistry | Yes | Yes |
| Voice → record draft | Yes | Not stated |
| HELFO tariff control vs. official source | Yes103 tariff codes verified figure by figure against the Directorate of Health circular and auto-cross-checked against Helfo open data | Not stated |
| X-ray AI (decision support) | Yes | YesSecond Opinion: FDA-cleared AI for pathology detection in 2D X-rays (vendor claim) |
| Voice-driven perio charting | Yes | Not stated |
| CBCT / 3D viewer | Yes | YesSecond Opinion 3D: color-coded 3D segmentation (nerve canal, sinus, airway, teeth), pathology detection (incl. periapical radiolucency, impactions, sinus radiopacities), 2D images for insurance claims |
| Drug interaction check | Yes | Not stated |
| Referral / discharge / letters | Yes | Partial“One-click” referral to a US board-certified radiologist inside the product – not Norwegian referral/discharge letters |
| Appointments and recall | Yes | Not stated |
| Patient communication | Yes | Not stated |
| AI shows its source (grounding) | YesGrounding score on every AI block — try it on /evidens | Not stated |
| Practice-system integration | PartialOpus export (clipboard/file); PMS integration in Enterprise tier | YesIntegrations with imaging/practice systems in the US market (Pearl Connect) |
| Flat price, all AI included | Yes | Not stated |
| CE-marked (EU MDR) | PartialApplication pending — Clinaxia is decision support, not CE-marked diagnostics | YesStates FDA clearance for both 2D and 3D; CE marking mentioned for Second Opinion (class not stated on the page) |
| ISO 27001 | NoNot certified yet | Not stated |
| Data location | EU/EEA | Not stated on the product page (US company) |
Documented on the website · Pearl (Second Opinion 3D)
Documented at Clinaxia
Measured in Clinaxia — not promised
See how we measure →103
HELFO tariffs verified against the Directorate of Health
100 %
match with Helfo open data (2026-11-07)
4.3
min measured active time per record (n=17)
599 · 556
test runs · regression suites
We only show what the vendor states itself. Where a website does not mention a feature, we write “not stated” — not “no”. Comparative advertising: the information is objective, verifiable and linked to its source. Report errors to hei@clinaxia.com — we correct within 48 hours.
No card. Every AI module included from day one.